North-Estonian Regional Hospital
Tallinn 13419
0 studies enrolling now · 3 studies all time
What they study most
Hormone-Refractory Prostate Cancer, Type 1 Diabetes Mellitus, Ulcerative Colitis and Crohn's Disease
Studies at this site
- A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes — Running, not enrolling
- Entyvio (Vedolizumab) Long Term Safety Study — Completed
- Multi-Center Phase II Study to Compare MER-101 20mg Tablets to Intravenous Zometa 4mg in Male Bisphosphonate-Naive, Hormone Refractory Prostate Cancer Patients — Completed